SCHEMBL30299191

SCHEMBL30299191

c1ccc(COc2ccc3c(c2)CCCC3)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.72
RXRA P19793 3/20 0.68
RXRB P28702 3/20 0.68
RXRG P48443 3/20 0.68
NPC1 O15118 3/20 0.68
RAB9A P51151 3/20 0.68
CYP2D6 P10635 3/20 0.66
MAOA P21397 2/20 0.64
MAOB P27338 2/20 0.64
POLB P06746 1/20 0.63
GFER P55789 1/20 0.63
PAX8 Q06710 1/20 0.63
KLF5 Q13887 1/20 0.63
MRGPRX4 Q96LA9 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
HRH1 P35367 1/20 0.62
ALDH1A1 P00352 1/20 0.59
TP53 P04637 1/20 0.59
MAPT P10636 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12472442 0.97 HRH3 (0.72) HRH3RXRARXRBRXRGNPC1
SCHEMBL17026485 0.87 MAOA (0.61) HRH3RXRARXRBRXRGNPC1
SCHEMBL3077665 0.85 HRH3 (0.67) HRH3RXRARXRBRXRGNPC1
SCHEMBL5450398 0.84 HRH3 (1.00) HRH3NPC1RAB9ACYP2D6HRH1
SCHEMBL13765599 0.84 HRH3 (0.57) HRH3RXRARXRBRXRGNPC1
SCHEMBL6420814 0.84 MAOA (0.65) HRH3RXRARXRBRXRGNPC1
SCHEMBL15818649 0.83 MAOA (0.66) HRH3RXRARXRBRXRGNPC1
SCHEMBL8462058 0.83 RXRB (0.61) HRH3RXRARXRBRXRGNPC1
Hydrochloric Acid SCHEMBL4937090 0.83 HRH3 (0.97) HRH3NPC1RAB9ACYP2D6HRH1
SCHEMBL6225615 0.83 MAOB (0.63) HRH3RXRARXRBRXRGNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119100936-A In the ilast group Synthesis method of intermediate 杭州诺澳生物医药科技有限公司 2024-12-10 CN disclosed
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. (US) 2023-09-14 US disclosed
US-11639333-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC (US) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM5A, KDM1A HRH3 309/4885RXRA 1998/4885RXRB 1590/4885
US-11639333-B2 Histone demethylase inhibitors KDM1B, KDM5A, KDM1A HRH3 309/4885RXRA 1998/4885RXRB 1590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.